论文部分内容阅读
流行性出血热(EHF)目前尚无特效治疗,对EHF患者使用激素治疗意见不一。兹将本科1982年12月至1986年6月所经治的85例EHF患者进行回顾性分析,以供商榷、参考。临床资料所有患者分为两组:早、中期激素组即观察组,计50例;未用激素组即对照组,计35例。观察组有危重型15例,普通型20例,轻型15例。对照组有危重型10例,普通型16例,轻型9例。为了提高论证的可靠性,非典型病例均予剔除。所有患者均按1981年全国流行性出血热会议的诊断及分型标准予以确诊。男73例,女12例,年龄5～70岁。观察组均在发病6日内入院。
Epidemic hemorrhagic fever (EHF) is currently no specific treatment, the use of hormone therapy in EHF different views. This article from December 1982 to June 1986 were treated 85 cases of EHF patients for retrospective analysis, for discussion, reference. Clinical data All patients were divided into two groups: early and mid-term hormones that the observation group, accounting for 50 cases; without hormone group that is the control group, 35 cases. The observation group had 15 cases of critical type, 20 cases of common type and 15 cases of light type. The control group had 10 cases of critical type, 16 cases of common type and 9 cases of light type. In order to improve the reliability of the demonstration, atypical cases were removed. All patients were diagnosed according to the diagnosis and classification criteria of the 1981 National Epidemic Haemorrhagic Fever Conference. 73 males and 12 females, aged 5 to 70 years. Observation group were admitted within 6 days of onset.